Expertise in
5
conditions

Roberto Bianco

Via Sergio Pansini, 5, Naples, 
Naples, IT 
Expertise in
5
conditions
Via Sergio Pansini, 5, Naples, 
Naples, IT 

Overview

Roberto Bianco practices practicing medicine in Naples, Italy.

Mr. Bianco is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cardiogenic Shock, Pancreatic Cancer, Colorectal Cancer, Transcatheter Aortic Valve Replacement (TAVR), and Lung Transplant.

He is actively involved in clinical research, co-authoring 166 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Via Sergio Pansini, 5, Naples, Naples, 80131, Italy
Other Locations
Caserta, Italy
Avellino, Italy
Padova, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in Combination With Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX as Neoadjuvant Treatment in Patients With Locally Advanced, Unresectable Pancreatic Cancer
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in Combination With Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX as Neoadjuvant Treatment in Patients With Locally Advanced, Unresectable Pancreatic Cancer
Enrollment Status: Completed
Publish Date: November 05, 2024
Intervention Type: Drug
Study Drugs: Pamrevlumab, Gemcitabine, Nab-paclitaxel, FOLFIRINOX
Study Phase: Phase 3

166 Total Publications

Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centers.
Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centers.
Journal: Annals of hematology
Published: June 17, 2026

Frequently Asked Questions about Roberto Bianco

Is Roberto Bianco a top-rated expert for Cardiogenic Shock?

MediFind is an objective health platform that identifies experts based on real-world data. Roberto Bianco is classified as an Advanced expert for Cardiogenic Shock, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Roberto Bianco participate in research or clinical trials?

Yes. Roberto Bianco has published 166 articles and abstracts on conditions like Cardiogenic Shock. You can view a list of Roberto Bianco's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bianco's expertise for a condition
ConditionClose
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile